人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin
產(chǎn)品名稱(chēng): 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin
產(chǎn)品型號(hào): C02-130-09-100ug
產(chǎn)品展商: peprotech
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin系列產(chǎn)品主要適用于試驗(yàn)室或生化科研相關(guān)試驗(yàn),CANSPEC品質(zhì)提供的人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin性能**,中文名稱(chēng)為人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin。產(chǎn)品人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin以其優(yōu)良的品質(zhì)滿(mǎn)足您不同科研實(shí)驗(yàn)的多種需求。
人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin
的詳細(xì)介紹
產(chǎn)品名稱(chēng):人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin
產(chǎn)品規(guī)格:
C02-130-09-100ug | 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin | 100ug | ¥9,800 |
C02-130-09-1mg | 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin | 1mg | ¥42,000 |
C02-130-09-25ug | 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin | 25ug | ¥1,960 |
C02-130-09-500ug | 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin | 500ug | ¥25,200 |
C02-130-09-5ug | 人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin | 5ug | ¥680 |
單 位:瓶
關(guān) 鍵 字:人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin
CANSPEC品質(zhì)提供的人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin性能**,英文名稱(chēng)人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin,簡(jiǎn)稱(chēng)為人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin,中文名稱(chēng)為人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin。
產(chǎn)品人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin以其優(yōu)良的品質(zhì)滿(mǎn)足您不同實(shí)驗(yàn)的多種需求。并保證每批人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin的質(zhì)量和人內(nèi)脂素|內(nèi)臟脂肪素|Human Visfatin品質(zhì)優(yōu)良。
Synonyms : | PBEF (Pre-B cell colony-enhancing factor) |
Description : | Visfatin is a 55 kDa protein produced and secreted primarily by white adipose tissue. Recently, Visfatin was isolated from visceral fat deposits and shown to possess insulin-mimetic activity. Like insulin, Visfatin exerts hypoglycemic effects by interacting with the insulin receptor. The binding affinity of Visfatin for the insulin receptor is similar to that of insulin, but it does not compete with insulin, suggesting that the two proteins interact with different receptor sites. The circulating levels of Visfatin are much lower than those of insulin and are not affected by feeding, implying that the hypoglycemic effect of Visfatin may not be of physiological importance. The plasma Visfatin levels, like those of Leptin, correlate positively with the percent of body fat and increase during the development of obesity. Another similarity between Visfatin and Leptin is that their amino acid sequence is highly conserved across different mammalian species and shows no homology to any known protein. Receptors for both Leptin (Ob-R) and Visfatin (i.e. the insulin receptor) are expressed by neurons within the arcuate nucleus of the hypothalamus, a brain area that plays a pivotal role in the regulation of energy metabolism. Although the metabolic function of Visfatin is still unknown, it appears that this newly identified adipocytokine might play an important role, similar to that of Leptin, in the regulation of body weight, i.e. as an afferent signal reflecting excess body fat. Recombinant human Visfatin is a 52.5 kDa protein containing 465 amino acid residues (isoform 1). |
Catalog #: | 130-09 |
Source : | E.coli |
Stability : | The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted Visfatin is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles. |
Purity : | Greater than 98% by SDS-PAGE gel and HPLC analyses. |
Endotoxin Level : | Endotoxin level is less than 0.1 ng per μg (1EU/μg). |
Biological Activity : | The ED50was determined by the dose-dependant proliferation of the RPMI 8226 cells. The expected ED50for this effect is 15.0-20.0 ng/ml. |
Selected References : | Selected List of References Citing This PeproTech Product |
AA Sequence : | MPPNTSKVYS YFECREKKTE NSKLRKVKYE ETVFYGLQYI LNKYLKGKVV TKEKIQEAKD VYKEHFQDDV FNEKGWNYIL EKYDGHLPIE IKAVPEGFVI PRGNVLFTVE NTDPECYWLT NWIETILVQS WYPITVATNS REQKKILAKY LLETSGNLDG LEYKLHDFGY RGVSSQETAG IGASAHLVNF KGTDTVAGLA LIKKYYGTKD PVPGYSVPAA EHSTITAWGK DHEKDAFEHI VTQFSSVPVS VVSDSYDIYN ACEKIWGEDL RHLIVSRSTQ APLIIRPDSG NPLDTVLKVL EILGKKFPVT ENSKGYKLLP PYLRVIQGDG VDINTLQEIV EGMKQKMWSI ENIAFGSGGG LLQKLTRDLL NCSFKCSYVV TNGLGINVFK DPVADPNKRS KKGRLSLHRT PAGNFVTLEE GKGDLEEYGQ DLLHTVFKNG KVTKSYSFDE IRKNAQLNIE LEAAHH |
PubMed Link : | Visfatin |
Country of Origin : | USA |